Edition:
United Kingdom

Avid Bioservices Inc (CDMO.OQ)

CDMO.OQ on NASDAQ Stock Exchange Capital Market

6.07USD
20 Jul 2018
Change (% chg)

$0.40 (+7.05%)
Prev Close
$5.67
Open
$5.64
Day's High
$6.09
Day's Low
$5.64
Volume
261,008
Avg. Vol
159,833
52-wk High
$6.09
52-wk Low
$2.25

Chart for

About

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products... (more)

Overall

Beta: 2.50
Market Cap(Mil.): $151.07
Shares Outstanding(Mil.): 45.10
Dividend: --
Yield (%): --

Financials

  CDMO.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.58 -- --
ROI: -36.53 15.07 14.61
ROE: -48.18 16.60 16.34

BRIEF-Avid Bioservices Provides Update On Ongoing Expansion Of Process Development Capabilities And Laboratory Infrastructure

* AVID BIOSERVICES PROVIDES UPDATE ON ONGOING EXPANSION OF PROCESS DEVELOPMENT CAPABILITIES AND LABORATORY INFRASTRUCTURE

24 Apr 2018

BRIEF-Avid Bioservices Selected By Acumen Pharmaceuticals To Lead Process Development And Clinical Manufacture Of Novel Alzheimer's Disease Candidate

* AVID BIOSERVICES SELECTED BY ACUMEN PHARMACEUTICALS TO LEAD PROCESS DEVELOPMENT AND CLINICAL MANUFACTURE OF NOVEL ALZHEIMER’S DISEASE CANDIDATE

01 Mar 2018

BRIEF-Avid Bioservices Announces Proposed Offering Of Common Stock

* AVID BIOSERVICES ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

14 Feb 2018

BRIEF-Avid Bioservices, Oncologie Enter Into Asset Assignment, Purchase Agreement For Avid's PS-Targeting Program Including Bavituximab

* AVID BIOSERVICES AND ONCOLOGIE ENTER INTO ASSET ASSIGNMENT AND PURCHASE AGREEMENT FOR AVID’S PS-TARGETING PROGRAM INCLUDING BAVITUXIMAB

12 Feb 2018

Competitors

  Price Chg
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥4,798 +131.00
HANALL BIOPHARMA (009420.KS) ₩25,050.00 -200.00
Pfizer Inc. (PFE.N) $37.33 -0.03
Johnson & Johnson (JNJ.N) $125.85 -0.09
Novartis AG (NOVN.S) CHF82.20 +1.24
Merck & Co., Inc. (MRK.N) $62.52 +0.01
Roche Holding Ltd. (ROG.S) CHF234.00 +2.05
Roche Holding Ltd. (RO.S) CHF238.60 +2.80
Bayer AG (BAYGn.DE) €92.05 -0.30
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates